Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2010) | Total Docs. (3years) | Total Refs. (2010) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2010) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 6.569 Q1 | 391 | 242 | 519 | 7490 | 5967 | 413 | 10.42 | 30.95 |  |
| 2 | Trends in Pharmacological Sciences | journal | 5.544 Q1 | 244 | 80 | 260 | 5902 | 3056 | 246 | 11.90 | 73.78 | |
| 3 | Cellular and Molecular Life Sciences | journal | 4.001 Q1 | 261 | 303 | 884 | 27854 | 6291 | 873 | 7.30 | 91.93 |  |
| 4 | Neuropsychopharmacology | journal | 3.368 Q1 | 249 | 249 | 805 | 16794 | 5537 | 779 | 6.87 | 67.45 | |
| 5 | Current Opinion in Pharmacology | journal | 3.365 Q1 | 148 | 112 | 323 | 5804 | 2372 | 294 | 7.00 | 51.82 |  |
| 6 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.236 Q1 | 70 | 0 | 12 | 0 | 109 | 12 | 11.80 | 0.00 |  |
| 7 | Neuropharmacology | journal | 2.355 Q1 | 191 | 225 | 821 | 12830 | 3992 | 813 | 5.12 | 57.02 | |
| 8 | Neurotherapeutics | journal | 2.320 Q1 | 136 | 53 | 220 | 4993 | 1477 | 206 | 6.90 | 94.21 | |
| 9 | Apoptosis : an international journal on programmed cell death | journal | 2.189 Q1 | 128 | 127 | 443 | 9032 | 2187 | 438 | 4.58 | 71.12 | |
| 10 | Journal of Antimicrobial Chemotherapy | journal | 2.161 Q1 | 221 | 419 | 1656 | 10729 | 7093 | 1289 | 4.26 | 25.61 | |
| 11 | Psychopharmacology | journal | 2.125 Q1 | 214 | 274 | 1086 | 14738 | 4830 | 1048 | 4.04 | 53.79 | |
| 12 | Drug Discovery Today | journal | 2.028 Q1 | 215 | 140 | 452 | 8078 | 3126 | 428 | 6.55 | 57.70 | |
| 13 | Drug and Alcohol Dependence | journal | 1.976 Q1 | 187 | 258 | 778 | 11526 | 3263 | 748 | 3.68 | 44.67 |  |
| 14 | International Journal of Neuropsychopharmacology | journal | 1.892 Q1 | 125 | 125 | 335 | 6482 | 1459 | 309 | 4.11 | 51.86 | |
| 15 | Antiviral Therapy | journal | 1.852 Q1 | 93 | 147 | 426 | 5522 | 1725 | 418 | 3.67 | 37.56 | |
| 16 | European Neuropsychopharmacology | journal | 1.692 Q1 | 130 | 95 | 332 | 5527 | 1462 | 326 | 4.43 | 58.18 | |
| 17 | BioDrugs | journal | 1.664 Q1 | 79 | 47 | 119 | 2941 | 576 | 111 | 5.36 | 62.57 | |
| 18 | Current Opinion in Drug Discovery and Development | journal | 1.661 Q1 | 85 | 68 | 221 | 4845 | 1124 | 204 | 5.31 | 71.25 | |
| 19 | Pharmacogenomics Journal | journal | 1.661 Q1 | 95 | 51 | 136 | 2259 | 714 | 133 | 4.63 | 44.29 | |
| 20 | Drug Safety | journal | 1.620 Q1 | 140 | 103 | 311 | 4330 | 1295 | 259 | 4.04 | 42.04 | |
| 21 | Expert Opinion on Therapeutic Targets | journal | 1.594 Q1 | 106 | 109 | 377 | 11083 | 1506 | 363 | 3.95 | 101.68 | |
| 22 | Clinical Pharmacokinetics | journal | 1.533 Q1 | 184 | 58 | 190 | 4333 | 1017 | 177 | 5.30 | 74.71 | |
| 23 | Clinical Trials | journal | 1.507 Q1 | 74 | 76 | 188 | 1771 | 404 | 153 | 2.13 | 23.30 | |
| 24 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 142 | 390 | 10509 | 1531 | 333 | 3.90 | 74.01 | |
| 25 | Antiviral Research | journal | 1.409 Q1 | 151 | 190 | 383 | 11217 | 1674 | 383 | 4.74 | 59.04 | |
| 26 | Expert Opinion on Investigational Drugs | journal | 1.367 Q1 | 117 | 149 | 508 | 11809 | 2156 | 487 | 4.39 | 79.26 | |
| 27 | Journal of Psychopharmacology | journal | 1.351 Q1 | 135 | 231 | 378 | 9785 | 1310 | 326 | 3.14 | 42.36 | |
| 28 | Current Opinion in Molecular Therapeutics | journal | 1.336 Q1 | 67 | 88 | 220 | 5913 | 801 | 203 | 3.88 | 67.19 | |
| 29 | ChemMedChem | journal | 1.294 | 119 | 211 | 603 | 9609 | 2141 | 592 | 3.38 | 45.54 | |
| 30 | Cardiovascular Drugs and Therapy | journal | 1.289 Q1 | 79 | 54 | 198 | 2365 | 535 | 157 | 2.70 | 43.80 | |
| 31 | Pharmacogenomics | journal | 1.281 Q1 | 100 | 190 | 537 | 7298 | 1961 | 454 | 3.61 | 38.41 | |
| 32 | Investigational New Drugs | journal | 1.265 Q1 | 97 | 108 | 211 | 3933 | 664 | 211 | 2.87 | 36.42 | |
| 33 | Current Opinion in Investigational Drugs | journal | 1.257 Q1 | 83 | 144 | 375 | 10224 | 1330 | 340 | 3.70 | 71.00 | |
| 34 | Expert Opinion on Biological Therapy | journal | 1.256 Q1 | 102 | 147 | 477 | 12860 | 1755 | 468 | 3.73 | 87.48 | |
| 35 | PharmacoEconomics | journal | 1.253 Q1 | 118 | 110 | 258 | 4458 | 813 | 205 | 3.39 | 40.53 | |
| 36 | Pharmaceutical Statistics | journal | 1.250 Q1 | 46 | 33 | 88 | 559 | 152 | 82 | 1.49 | 16.94 | |
| 37 | Current Drug Metabolism | journal | 1.247 Q1 | 122 | 73 | 280 | 7949 | 1367 | 265 | 4.58 | 108.89 | |
| 38 | Cancer Chemotherapy and Pharmacology | journal | 1.219 Q1 | 122 | 250 | 754 | 7824 | 2299 | 739 | 3.01 | 31.30 | |
| 39 | British Journal of Clinical Pharmacology | journal | 1.194 Q1 | 167 | 202 | 734 | 5994 | 2285 | 550 | 3.04 | 29.67 | |
| 40 | Journal of Ethnopharmacology | journal | 1.193 Q1 | 231 | 529 | 1378 | 19441 | 4946 | 1370 | 3.11 | 36.75 | |
| 41 | Skin Pharmacology and Physiology | journal | 1.117 Q1 | 86 | 56 | 122 | 2143 | 436 | 109 | 3.11 | 38.27 | |
| 42 | Phytomedicine | journal | 1.062 Q1 | 141 | 193 | 456 | 6043 | 1544 | 447 | 3.11 | 31.31 | |
| 43 | European Journal of Clinical Pharmacology | journal | 1.060 Q1 | 123 | 183 | 501 | 5329 | 1515 | 427 | 3.11 | 29.12 | |
| 44 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 1.054 Q1 | 99 | 101 | 328 | 4316 | 919 | 327 | 2.76 | 42.73 | |
| 45 | European Journal of Pharmacology | journal | 1.043 Q2 | 203 | 686 | 2229 | 29037 | 6842 | 2225 | 3.11 | 42.33 | |
| 46 | Expert Opinion on Drug Metabolism and Toxicology | journal | 1.043 Q2 | 100 | 121 | 315 | 10240 | 1249 | 310 | 3.82 | 84.63 | |
| 47 | CNS Neuroscience and Therapeutics | journal | 1.013 Q2 | 91 | 52 | 66 | 4399 | 258 | 63 | 3.91 | 84.60 | |
| 48 | Inflammation and Allergy - Drug Targets | journal | 1.004 Q2 | 55 | 43 | 116 | 4170 | 408 | 113 | 3.51 | 96.98 | |
| 49 | Cardiovascular Therapeutics | journal | 0.996 Q2 | 54 | 59 | 69 | 3319 | 171 | 63 | 2.48 | 56.25 | |
| 50 | Expert Opinion on Emerging Drugs | journal | 0.984 Q2 | 54 | 47 | 133 | 4968 | 471 | 133 | 3.91 | 105.70 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data